Liquid Biopsies – News and Features

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.

Engineered bacteria can detect tumor DNA shed by colon cancers into the gastrointestinal (GI) tract in mice, creating the potential for their use as biosensors to detect and respond to disease.

Short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment.

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.

Researchers have developed a way to simultaneously measure different characteristics of circulating tumour DNA, to detect and localise multiple cancer types at an early stage.

Researchers have developed a technique called diffuse in-vivo flow cytometry (DiFC) to detect and count the number of circulating tumor cells.

A group has developed a technology to capture and release cell-free DNA on nanowire surfaces from urine. By extracting this DNA, they were able to successfully detect IDH1 mutation, a characteristic genetic mutation of gliomas, a type of brain tumor.

This article will discuss how cell models are enabling researchers to elucidate the underlying biological mechanisms of disease to support diagnostic and therapeutic development.

In a new study, the team developed a comprehensive and high-resolution methylation atlas based on a vast dataset of 521 noncancerous tissue samples representing 29 major types of human tissues.

This marker could help identify patients who need different treatments for hepatocellular carcinoma.